Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma
Journal article published in 2020 by
Marine Baron 
,
Lisa Belin,
Nathalie Cassoux,
Christine Fardeau,
Marion Blaizeau,
Carole Soussain,
Caroline Houillier,
Khê Hoang-Xuan,
Emmanuel Gyan ,
Marie-Laure Le Lez,
Anne Lavaud,
Pierre Soubeyran,
Bahram Bodaghi,
Myrto Costopoulos,
Veronique Leblond
and other authors.
,
Lisa Belin,
Nathalie Cassoux,
Christine Fardeau,
Marion Blaizeau,
Carole Soussain,
Caroline Houillier,
Khê Hoang-Xuan,
Emmanuel Gyan ,
Marie-Laure Le Lez,
Anne Lavaud,
Pierre Soubeyran,
Bahram Bodaghi,
Myrto Costopoulos,
Veronique Leblond
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Baron et al report excellent responses to temozolomide in 21 patients (19 relapsed/refractory) with primary vitreoretinal lymphoma. Treatment is well tolerated, even in elderly patients.